Submitted by Anonymous (not verified) on 17 June 2025 - 14:35
Human medicines European public assessment report (EPAR): Arexvy, recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 6, Status: Authorised
Source: